-+ 0.00%
-+ 0.00%
-+ 0.00%

Ocular Therapeutix to Present SOL-1 Phase 3 AXPAXLI Wet AMD Trial Results Slides

Reuters·02/27/2026 21:03:41

Please log in to view news